$IFF

IFF (IFF) Q2 2026 Earnings Call Transcript

International Flavors & Fragrances (IFF) reported Q2 2026 revenue from continuing operations of $1.95 billion, up 6% currency-neutral, and adjusted EPS ex amortization of $0.82. Adjusted operating EBITDA was $408 million. The company plans a $4.3 billion Food Ingredients divestiture, $1B+ debt reduction, and a $2.5 billion share buyback. 2026 guidance: revenue $7.4B-$7.6B, EBITDA $1.53B-$1.60B.

Original reporting
Published Aug 13, 2026, 12:43 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 2:05 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
IFF (IFF) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$IFFBullishMed
01

Why it matters

Traders can update models for 2026 revenue/EBITDA ranges, cash flow trajectory (working capital and stranded costs), and capital allocation (debt reduction and repurchases) following the divestiture plan.

02

Market read

The call provides concrete guidance ranges and capital allocation commitments that can drive near-term repricing, while also flagging quantified cash headwinds tied to separation.

03

What to watch

The article notes factoring-related unwind and stranded costs, but does not quantify divestiture timing certainty or the sensitivity of segment margins to energy/logistics beyond customer surcharges.

Relevance 8/10Novelty 7/10Timing: post-earnings call, guidance and capital allocation details for 2026

Background

International Flavors & Fragrances (IFF) used its Q2 2026 earnings call to detail portfolio transformation via divestitures and to reset full-year 2026 guidance on continuing operations.

Company-level read

Ticker impact

$IFFBullishMedium confidence
Context

IFF reported Q2 2026 results and updated 2026 guidance on a continuing-operations basis, alongside a $4.3B Food Ingredients divestiture and $2.5B buyback authorization.

Expected impact

Moderate positive bias for the next few sessions as traders price the guidance and capital-return plan, with volatility around separation-related working-capital headwinds.

Evidence & confidence

The article discloses concrete, decision-relevant items: Q2 adjusted EPS and EBITDA, full-year revenue and EBITDA guidance ranges, $4.3B divestiture valuation (~10x EV/EBITDA), >$1B debt reduction plan, and $2.5B repurchase authorization, plus quantified headwinds (~$200M) and stranded-cost elimination plan ($100M).

Market effects

Food ingredients and flavor/fragrance peers may face read-across on margin durability, energy/logistics pass-through, and portfolio simplification strategy.

Asia-led Taste growth and Middle East conflict commentary highlight regional demand and volatility drivers for consumer-adjacent ingredients.

Macro and conflict-driven risk framing can influence broader sentiment toward discretionary-linked ingredient demand and input-cost pass-through.

Counterpoint

The guidance and buyback narrative may be offset by separation execution risk, with working-capital headwinds and stranded-cost remediation potentially delaying cash conversion.

Key entities

  • International Flavors & Fragrances Inc.

    Reported Q2 2026 results, provided 2026 continuing-operations guidance, and outlined a $4.3B Food Ingredients divestiture plus $2.5B share repurchase authorization.

  • Jon Erik Fyrwald

    CEO who discussed portfolio positioning, innovation/R&D priorities, and risk management around demand and geopolitics.

  • Michael DeVeau

    CFO who discussed guidance range drivers, working-capital headwinds, and cost inflation pass-through.

  • CVC

    Named as the buyer in the Food Ingredients divestiture transaction described in the call.

Related articles

$DARMedAI 8/10

A Look Back at Ingredients, Flavors & Fragrances Stocks’ Q2 Earnings: Darling Ingredients (NYSE:DAR) Vs The Rest Of The Pack

Ingredients, flavors, and fragrances stocks reported mixed Q2 earnings, with revenues missing estimates by 2.4%. Darling Ingredients (DAR) reported $1.72B revenue, up 16.4% YoY, beating estimates. Archer-Daniels-Midland (ADM) reported $22.68B revenue, up 7.2% YoY, outperforming estimates. International Flavors & Fragrances (IFF) reported $1.95B revenue, down 29.3% YoY, missing estimates. Ingredion (INGR) reported $1.85B revenue, flat YoY, topping estimates. Bunge Global (BG) reported $24.04B rev

$IFFMedAI 8/10

Read Analyst Questions From International Flavors & Fragrances’s Q2 Earnings Call

International Flavors & Fragrances (IFF) reported Q2 results driven by volume growth in Scent, Taste, and Health & Biosciences, with productivity improvements and margin discipline. Q2 revenue fell to $1.95B vs $2.61B estimates, and adjusted EPS was $0.82 vs $1.12. Full-year revenue guidance was cut to $7.5B midpoint from $10.65B. CEO said Food Ingredients divestiture is likely the last major portfolio change.

$IFFMedAI 8/10

International Flavors & Fragrances Q2 Earnings Call Highlights

International Flavors & Fragrances (IFF) reported Q2 segment results: Taste sales rose 4% to $688M, Health & Biosciences sales rose 5% to $601M, and Scent sales rose 8% to $665M. EBITDA increased across segments. IFF agreed to sell Food Ingredients to CVC for about $4.3B, and set 2026 guidance for $7.4B-$7.6B sales and $1.53B-$1.6B EBITDA.

$IFFMed

Why International Flavors & Fragrances (IFF) Is Up 6.4% After New $2.5 Billion Buyback And Guidance

International Flavors & Fragrances (IFF) reported Q2 2026 sales of US$1,954 million and net income of US$50 million, with full-year guidance updated for discontinued operations. The company also authorized a new US$2.5 billion share repurchase and reaffirmed its quarterly dividend. The article links the buyback and portfolio reshaping to IFF’s risk and cash-generation outlook.

$IFFMed

Why is International Flavors & Fragrances stock climbing today?

International Flavors & Fragrances (IFF) shares rose 0.8% in pre-open trading. The company said it will sell its Food Ingredients business to CVC Capital Partners for about $4.3 billion, expected to close by end of Q2 2027, and announced a $2.5 billion share repurchase. Q2 adjusted EPS was $0.82 vs $1.09 expected, revenue $1.95B vs $2.68B, but core results improved. Oppenheimer raised its IFF price target to $95 from $90.